Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 GlucaGen (Glucagon rDNA) Injection
Company:  Novo Nordisk Pharmaceuticals, Inc.
Application No.:  020918
Approval Date: 6/22/1998


Date created: June 23, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.